Which intranasal spray is recommended for relief of nasal congestion?

Intranasal Corticosteroids Are the First-Line Treatment for Nasal Congestion

For nasal congestion, intranasal corticosteroids (INCS) are the recommended first-line therapy, as they are the most effective medication class for controlling nasal symptoms. 1

Primary Recommendation

• Intranasal corticosteroids alone should be used as initial treatment for nasal congestion in both seasonal and perennial allergic rhinitis, as they provide superior symptom control compared to other medication classes. 1
• The 2017 Joint Task Force guidelines explicitly state that intranasal corticosteroids are "the most effective medication class for controlling symptoms" of allergic rhinitis. 1

When to Consider Combination Therapy

For patients with moderate to severe seasonal allergic rhinitis, combination therapy may provide additional benefit:

• Intranasal corticosteroid plus intranasal antihistamine (such as fluticasone propionate plus azelastine) can be considered for initial treatment in patients aged 12 years or older with moderate to severe symptoms. 1
• This combination provides faster onset of action (particularly in the first 2 weeks) and greater symptom reduction than either agent alone, with reductions in total nasal symptom scores of 5.31-5.7 points compared to 3.84-5.1 for intranasal corticosteroids alone. 1
• The combination therapy showed greater than 40% relative improvement compared with either agent alone. 1
• However, for perennial allergic rhinitis, intranasal corticosteroids alone are preferred over combination therapy, as there is no additional benefit from adding an oral or intranasal antihistamine. 1

Role of Topical Decongestants

For acute nasal congestion from common cold or upper respiratory infection:

• Oxymetazoline 0.05% nasal spray provides rapid, clinically meaningful relief of nasal congestion for up to 12 hours following a single dose. 2
• Xylometazoline 0.1% nasal spray is also effective, providing superior decongestant effect compared to placebo for up to 10 hours. 3
• Critical caveat: These topical decongestants should be used for short-term only (less than 10 days) to avoid rhinitis medicamentosa (rebound congestion). 4, 5
• Extended use up to 4 weeks of oxymetazoline in research settings did not show rebound congestion, but this is not recommended for routine clinical practice. 6

Combination for Common Cold

• Xylometazoline plus ipratropium bromide provides simultaneous relief of both nasal congestion and rhinorrhea in common cold, with high patient satisfaction (79% rating treatment as "good" to "excellent"). 4, 5
• This combination addresses both symptoms more effectively than either agent alone. 4

Practical Algorithm

1. For allergic rhinitis-related congestion: Start with intranasal corticosteroid monotherapy
2. For moderate-severe seasonal allergic rhinitis: Consider intranasal corticosteroid + intranasal antihistamine combination
3. For acute common cold congestion: Use topical decongestant (oxymetazoline or xylometazoline) for ≤10 days
4. For common cold with congestion + rhinorrhea: Consider xylometazoline + ipratropium combination

Common Pitfalls to Avoid

• Do not use oral antihistamines as first-line for nasal congestion - they are less effective than intranasal corticosteroids. 1
• Do not extend topical decongestant use beyond 10 days in routine practice to prevent rhinitis medicamentosa. 4, 5
• Do not add oral antihistamines to intranasal corticosteroids for perennial allergic rhinitis - this provides no additional benefit and increases cost and potential adverse effects. 1